Related references
Note: Only part of the references are listed.Autosomal Dominant Polycystic Kidney Patients May Be Predisposed to Various Cardiomyopathies
Fouad T. Chebib et al.
KIDNEY INTERNATIONAL REPORTS (2017)
Modulation of Polycystic Kidney Disease Severity by Phosphodiesterase 1 and 3 Subfamilies
Hong Ye et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease
Cibele S. Pinto et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Cyclic nucleotide phosphodiesterases in heart and vessels: A therapeutic perspective
Pierre Bobin et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2016)
A PDE3A mutation in familial hypertension and brachydactyly syndrome
Hiroko Boda et al.
JOURNAL OF HUMAN GENETICS (2016)
Ca2+/calmodulin-activated phosphodiesterase 1A is highly expressed in rabbit cardiac sinoatrial nodal cells and regulates pacemaker function
Yevgeniya O. Lukyanenko et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Cardiac dysfunction in Pkd1-deficient mice with phenotype rescue by galectin-3 knockout
Bruno E. Balbo et al.
KIDNEY INTERNATIONAL (2016)
New-onset Atrial Fibrillation is Associated With Polycystic Kidney Disease A Nationwide Population-based Cohort Study
Tung-Min Yu et al.
MEDICINE (2016)
Modulation of Compartmentalised Cyclic Nucleotide Signalling via Local Inhibition of Phosphodiesterase Activity
Marcella Brescia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Polycystin-1 Is a Cardiomyocyte Mechanosensor That Governs L-Type Ca2+ Channel Protein Stability
Zully Pedrozo et al.
CIRCULATION (2015)
Role of cAMP-Phosphodiesterase 1C Signaling in Regulating Growth Factor Receptor Stability, Vascular Smooth Muscle Cell Growth, Migration, and Neointimal Hyperplasia
Yujun Cai et al.
CIRCULATION RESEARCH (2015)
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Arlene B. Chapman et al.
KIDNEY INTERNATIONAL (2015)
Autosomal dominant polycystic kidney disease: the changing face of clinical management
Albert C. M. Ong et al.
LANCET (2015)
Vasopressin and disruption of calcium signalling in polycystic kidney disease
Fouad T. Chebib et al.
NATURE REVIEWS NEPHROLOGY (2015)
Gene-centric Meta-analysis in 87,736 Individuals of European Ancestry Identifies Multiple Blood-Pressure-Related Loci
Vinicius Tragante et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2014)
Strategies Targeting cAMP Signaling in the Treatment of Polycystic Kidney Disease
Vicente E. Torres et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Adenylyl Cyclase 6 Deficiency Ameliorates Polycystic Kidney Disease
Sara Rees et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Phosphodiesterase 1A Modulates Cystogenesis in Zebrafish
Caroline R. Sussman et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Decreased polycystin 2 expression alters calcium-contraction coupling and changes β-adrenergic signaling pathways
Ivana Y. Kuo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy
Jere Paavola et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial
Anna Caroli et al.
LANCET (2013)
Regulation of renin secretion by renal juxtaglomerular cells
Ulla G. Friis et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2013)
Cardiovascular Complications in Autosomal Dominant Polycystic Kidney Disease
Tevfik Ecder
CURRENT HYPERTENSION REVIEWS (2013)
Cyclic Nucleotide Phosphodiesterase 3 Signaling Complexes
F. Ahmad et al.
HORMONE AND METABOLIC RESEARCH (2012)
Profiling of cAMP and cGMP phosphodiesterases in isolated ventricular cardiomyocytes from human hearts: Comparison with rat and guinea pig
W. B. Johnson et al.
LIFE SCIENCES (2012)
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart
Clint L. Miller et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
PDE1 isozymes, key regulators of pathological vascular remodeling
Stefan Chan et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Tolvaptan inhibits ERK-dependent cell proliferation, Cl- secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin
Gail A. Reif et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Ca2+/calmodulin-stimulated PDE1 regulates the beta-catenin/TCF signaling through PP2A B56 gamma subunit in proliferating vascular smooth muscle cells
Kye-Im Jeon et al.
FEBS JOURNAL (2010)
Cyclic nucleotide signaling in polycystic kidney disease
Xiaofang Wang et al.
KIDNEY INTERNATIONAL (2010)
Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues
Viktor Lakics et al.
NEUROPHARMACOLOGY (2010)
Concerted Regulation of cGMP and cAMP Phosphodiesterases in Early Cardiac Hypertrophy Induced by Angiotensin II
Walid Mokni et al.
PLOS ONE (2010)
Calcium-dependent phosphodiesterase 1C inhibits renin release from isolated juxtaglomerular cells
M. Cecilia Ortiz-Capisano et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2009)
Role of Ca2+/Calmodulin-Stimulated Cyclic Nucleotide Phosphodiesterase 1 in Mediating Cardiomyocyte Hypertrophy
Clint L. Miller et al.
CIRCULATION RESEARCH (2009)
The use of total protein stains as loading controls: An alternative to high-abundance single-protein controls in semi-quantitative immunoblotting
Georgina M. Aldridge et al.
JOURNAL OF NEUROSCIENCE METHODS (2008)
Vasopressin directly regulates cyst growth in polycystic kidney disease
Xiaofang Wang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Cyclic nucleotide phosphodiesterase PDE1C1 in human cardiac myocytes
Fabrice Vandeput et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Vasopressin V2 receptor expression along rat, mouse, and human renal epithelia with focus on TAL
K. Mutig et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Compartmentalization of cAMP-dependent signaling by phosphodiesterase-4D is involved in the regulation of vasopressin-mediated water reabsorption in renal principal cells
Eduard Stefan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Role of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival
DJ Nagel et al.
CIRCULATION RESEARCH (2006)
Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use
Andrew T. Bender et al.
PHARMACOLOGICAL REVIEWS (2006)
Isoforms of cyclic nucleotide phosphodiesterase PDE3 and their contribution to cAMP hydrolytic activity in subcellular fractions of human myocardium
R Hambleton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Differential distribution of the vasopressin V2 receptor along the rat nephron during renal ontogeny and maturation
JM Sarmiento et al.
KIDNEY INTERNATIONAL (2005)
Ca2+-calmodulin-dependent phosphodiesterase (PDE1):: Current perspectives
TA Goraya et al.
CELLULAR SIGNALLING (2005)
Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways - Based on the Anniversary Prize of the Gesellschaft fur Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the special FEBS meeting in Brussels
N Dumaz et al.
FEBS JOURNAL (2005)
Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease
VE Torres et al.
NATURE MEDICINE (2004)
Structural basis for the activity of drugs that inhibit phosphodiesterases
GL Card et al.
STRUCTURE (2004)
Differential regulation of mesangial cell mitogenesis by cAMP phosphodiesterase isozymes 3 and 4
JF Cheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist
VH Gattone et al.
NATURE MEDICINE (2003)
Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys
T Yamaguchi et al.
KIDNEY INTERNATIONAL (2003)
A polycystin-2-like large conductance cation channel in rat left ventricular myocytes
T Volk et al.
CARDIOVASCULAR RESEARCH (2003)
Cyclic nucleotide phosphodiesterase 1C promotes human arterial smooth muscle cell proliferation
SD Rybalkin et al.
CIRCULATION RESEARCH (2002)
Nephron distribution of total low Km cyclic AMP phosphodiesterase in mouse, rat and rabbit kidney
E Kusano et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Inhibition of platelet-derived growth factor-induced mitogenesis by phosphodiesterase 3 inhibitors -: Role of protein kinase A in vascular smooth muscle cell mitogenesis
MT Osinski et al.
BIOCHEMICAL PHARMACOLOGY (2000)
cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway
T Yamaguchi et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
